{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:50:13Z","timestamp":1793346613504,"version":"4.5.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Previously, colorectal liver metastases (CLMs) were a highly morbid condition, for which standard palliative chemoradiation conferred dismal survival. Liver transplantation has emerged as a promising treatment for CLM; however, access has been limited to patients without a history of hepatic artery infusion pump (HAIP) therapy and those with access to living donors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Design:<\/jats:title>\n                    <jats:p>Six centers participated in a retrospective cohort study evaluating patients undergoing deceased donor liver transplantation (DDLT) for CLM. Our primary endpoints were overall (OS) and disease-free survival (DFS). A subanalysis was performed based on HAIP therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Thirty-five patients with CLM were transplanted using DDLT, of whom 15 experienced recurrence (42.9%). Patients underwent primary resection a median of 146 days from diagnosis. Nineteen patients underwent HAIP therapy (54.3%). KRAS mutation was statistically significantly associated with recurrence (p = 0.01). Transplant was performed a median of 1,079 days (35.5 months) from diagnosis, at a median model for end-stage liver disease score of 7. Of those who recurred, median time to recurrence was 218 days and most metastasized to the lung (11) followed by the liver (5). Overall DFS was 62.7% at 1 year and 53.2% at 2 years. Most patients who recurred remain alive: overall, OS was 96.9% at 1 year and 84.8% at 2 years. HAIP therapy was not associated with differences in DFS or OS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>DDLT confers favorable long-term OS to patients with CLM. Although HAIP did not confer improved survival in this cohort, larger studies assessing its impact are necessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/xcs.0000000000001925","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:05:34Z","timestamp":1773835534000},"page":"262-271","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Deceased Donor Liver Transplantation and Postoperative Survival in Patients with Unresectable Colorectal Liver Metastases: A Retrospective Multicenter Study"],"prefix":"10.1097","volume":"243","author":[{"given":"Angela L","family":"Hill","sequence":"first","affiliation":[{"name":"From the Department of Surgery, Washington University in St Louis, St Louis, MO (Hill, Cullinan, Ahmed, Chapman, Doyle)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren R","family":"Cullinan","sequence":"additional","affiliation":[{"name":"From the Department of Surgery, Washington University in St Louis, St Louis, MO (Hill, Cullinan, Ahmed, Chapman, Doyle)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Ahmed","sequence":"additional","affiliation":[{"name":"From the Department of Surgery, Washington University in St Louis, St Louis, MO (Hill, Cullinan, Ahmed, Chapman, Doyle)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Wesson","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University, Baltimore, MD (Wesson)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Samstein","sequence":"additional","affiliation":[{"name":"Department of Surgery, Cornell University, New York, NY (Samstein)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Surgery, Cleveland Clinic, Cleveland, OH (Hashimoto)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parissa","family":"Tabrizian","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mount Sinai, New York, NY (Tabrizian)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimul","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Surgery, Massachusetts General Hospital, Boston, MA (Shah)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C","family":"Chapman","sequence":"additional","affiliation":[{"name":"From the Department of Surgery, Washington University in St Louis, St Louis, MO (Hill, Cullinan, Ahmed, Chapman, Doyle)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majella B","family":"Doyle","sequence":"additional","affiliation":[{"name":"From the Department of Surgery, Washington University in St Louis, St Louis, MO (Hill, Cullinan, Ahmed, Chapman, Doyle)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the DDLT CLM Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"R1-20260819","first-page":"10","article-title":"Cancer statistics, 2025.","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"R2-20260819","doi-asserted-by":"crossref","first-page":"e2236666","DOI":"10.1001\/jamanetworkopen.2022.36666","article-title":"Incidence and survival in synchronous and metachronous liver metastases from colorectal cancer.","volume":"5","author":"Reboux","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R3-20260819","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.ejso.2022.06.021","article-title":"Prediction of survival in patients with colorectal liver metastases-development and validation of a prognostic score model.","volume":"48","author":"Villard","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"R4-20260819","doi-asserted-by":"crossref","first-page":"e232932","DOI":"10.1001\/jamasurg.2023.2932","article-title":"Long-term survival, prognostic factors, and selection of patients with colorectal cancer for liver transplant: a nonrandomized controlled trial.","volume":"158","author":"Dueland","year":"2023","journal-title":"JAMA Surg"},{"key":"R5-20260819","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(24)01595-2","article-title":"Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial.","volume":"404","author":"Adam","year":"2024","journal-title":"Lancet (London, England)"},{"key":"R6-20260819","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamasurg.2022.0300","article-title":"Recipient and donor outcomes after living-donor liver transplant for unresectable colorectal liver metastases.","volume":"157","author":"Hernandez-Alejandro","year":"2022","journal-title":"JAMA Surg"},{"key":"R7-20260819","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJMoa1908075","article-title":"Encorafenib, binimetinib, and cetuximab in BRAF V600E\u2013mutated colorectal cancer.","volume":"381","author":"Kopetz","year":"2019","journal-title":"N Engl J Med"},{"key":"R8-20260819","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/LVT.0000000000000535","article-title":"Pretransplant metabolic tumor volume predicts recurrence following liver transplantation for colorectal metastasis: a multicenter study.","volume":"31","author":"Wehrle","year":"2025","journal-title":"Liver Transpl"},{"key":"R9-20260819","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.cgh.2014.05.020","article-title":"Neighborhood level effects of socioeconomic status on liver transplant selection and recipient survival.","volume":"12","author":"Quillin Iii","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R10-20260819","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/lt.24147","article-title":"Racial and ethnic disparities in access to and utilization of living donor liver transplants.","volume":"21","author":"Nobel","year":"2015","journal-title":"Liver Transplant"},{"key":"R11-20260819","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1245\/s10434-023-13147-6","article-title":"The current state of liver transplantation for colorectal liver metastases in the United States: a call for standardized reporting.","volume":"30","author":"Sasaki","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"R12-20260819","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.ajt.2024.03.013","article-title":"Liver machine perfusion technology: expanding the donor pool to improve access to liver transplantation.","volume":"24","author":"Canizares","year":"2024","journal-title":"Am J Transplant"},{"key":"R13-20260819","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1097\/TP.0000000000000723","article-title":"Variable use of model for end-stage liver disease exception points in patients with neuroendocrine tumors metastatic to the liver and its impact on patient outcomes.","volume":"99","author":"Nobel","year":"2015","journal-title":"Transplantation"},{"key":"R14-20260819","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1245\/s10434-023-13652-8","article-title":"Liver transplantation after hepatic artery infusion pump therapy: single-center experience and technical considerations.","volume":"30","author":"Hill","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"R15-20260819","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/LVT.0000000000000397","article-title":"Hepatic artery infusion pump for unresectable colorectal liver metastases before living donor liver transplant: oncological friend or technical foe?","volume":"30","author":"Goldaracena","year":"2024","journal-title":"Liver Transplant"},{"key":"R16-20260819","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/jamaoncol.2016.4227","article-title":"Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis.","volume":"3","author":"Petrelli","year":"2017","journal-title":"JAMA Oncol"},{"key":"R17-20260819","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-017-3925-x","article-title":"Colorectal cancer liver metastases\u2014a population-based study on incidence, management and survival.","volume":"18","author":"Engstrand","year":"2018","journal-title":"BMC Cancer"},{"key":"R18-20260819","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-06784-7","article-title":"Right and left-sided colon cancers-specificity of molecular mechanisms in tumorigenesis and progression.","volume":"20","author":"Mukund","year":"2020","journal-title":"BMC Cancer"},{"key":"R19-20260819","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/bjs5.50280","article-title":"Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.","volume":"4","author":"Tai","year":"2020","journal-title":"BJS Open"},{"key":"R20-20260819","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1038\/s41591-024-03254-6","article-title":"ctDNA-based molecular residual disease and survival in resectable colorectal cancer.","volume":"30","author":"Nakamura","year":"2024","journal-title":"Nat Med"},{"key":"R21-20260819","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s11605-023-05723-8","article-title":"Liquid biopsy by ctDNA in liver transplantation for colorectal cancer liver metastasis.","volume":"27","author":"Wehrle","year":"2023","journal-title":"J Gastrointest Surg"},{"key":"R22-20260819","doi-asserted-by":"crossref","first-page":"e2300111","DOI":"10.1200\/CCI.23.00111","article-title":"Circulating tumor DNA in colorectal cancer liver metastasis: analysis of patients receiving liver resection and transplant.","volume":"7","author":"Wehrle","year":"2023","journal-title":"JCO Clin Cancer Inform"}],"container-title":["Journal of the American College of Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/XCS.0000000000001925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:01:01Z","timestamp":1787166061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/XCS.0000000000001925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/xcs.0000000000001925","relation":{},"ISSN":["1072-7515","1879-1190"],"issn-type":[{"value":"1072-7515","type":"print"},{"value":"1879-1190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]}}}